Unlock stock picks and a broker-level newsfeed that powers Wall Street.
11.58
-0.30
(-2.53%)
At close: April 4 at 5:29:39 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
133,940
133,940
112,157
56,979
31,726
Cost of Revenue
6,187
6,187
28,512
22,016
10,883
Gross Profit
127,754
127,754
83,646
34,962
20,843
Operating Expense
177,178
177,178
175,602
131,900
110,544
Operating Income
-49,424
-49,424
-91,956
-96,938
-89,701
Net Non Operating Interest Income Expense
342
342
-3,026
-9,326
-4,428
Pretax Income
-49,083
-49,083
-130,655
-99,656
-94,129
Tax Provision
573
573
-162
-268
-211
Net Income Common Stockholders
-49,657
-49,657
-130,493
-99,388
-93,918
Diluted NI Available to Com Stockholders
-49,657
-49,657
-130,493
-99,388
-93,918
Basic EPS
-0.90
-0.50
-1.60
-1.70
-1.90
Diluted EPS
-0.90
-0.50
-1.60
-1.70
-1.90
Basic Average Shares
98,557.65
99,314
81,558.13
58,603
48,403.49
Diluted Average Shares
98,557.65
99,314
81,558.13
58,603
48,403.49
Total Operating Income as Reported
-49,426
-49,426
-91,956
-96,937
-89,702
Total Expenses
183,365
183,365
204,114
153,916
121,427
Net Income from Continuing & Discontinued Operation
-49,657
-49,657
-130,493
-99,388
-93,918
Normalized Income
-49,657
-49,657
-94,864.23
-99,388
-93,918
Interest Income
--
--
1,466
102
1
Interest Expense
--
--
3,738
9,428
4,429
Net Interest Income
342
342
-3,026
-9,326
-4,428
EBIT
-49,424
-49,424
-91,956
-90,228
-89,700
EBITDA
-49,424
-49,424
-91,956
-80,510
-79,967
Reconciled Cost of Revenue
6,187
6,187
28,512
22,016
10,883
Reconciled Depreciation
--
--
24,352
9,718
9,733
Net Income from Continuing Operation Net Minority Interest
-49,657
-49,657
-130,493
-99,388
-93,918
Total Unusual Items Excluding Goodwill
--
--
-35,673
--
--
Total Unusual Items
--
--
-35,673
--
--
Normalized EBITDA
-49,424
-49,424
-56,283
-80,510
-79,967
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
-44.23
--
--
12/31/2021 - 5/24/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PAX.ST Paxman AB (publ)
68.20
-3.40%
ISAB.ST Inhalation Sciences Sweden AB
0.7760
-10.80%
DEAR.ST Duearity AB (publ)
0.0154
0.00%
TENDO.ST Tendo AB
1.4200
+6.77%
BIOVIT.ST Bio Vitos Pharma AB (publ)
0.2160
+60.59%
SPEC.ST SpectraCure AB (publ)
1.7000
-6.49%
QLINEA.ST Q-linea AB (publ)
0.0356
-5.57%
IMP-A-SDB.ST Implantica AG
27.00
-3.57%
QLIFE.ST Qlife Holding AB (publ)
1.9900
-3.40%
XVIVO.ST Xvivo Perfusion AB (publ)
261.00
-6.12%